ABBOTT LABORATORIES acquires Cardiovascular Systems, Inc. (CSI)
Snapshot
ABBOTT LABORATORIES acquired Cardiovascular Systems, Inc. (CSI) in April 2023. Cardiovascular Systems, Inc. (CSI) is a St. Paul, Minnesota, USA-based Medical devices — vascular business.
- Acquirer
- ABBOTT LABORATORIES
- Target
- Cardiovascular Systems, Inc. (CSI)
- Value
- (not disclosed)
- Date
- April 2023
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
ABBOTT LABORATORIES acquired Cardiovascular Systems, Inc. (CSI), a transaction completed in April 2023.
Cardiovascular Systems, Inc. (CSI) operates in Medical devices — vascular, is based in St. Paul, Minnesota, USA. Cardiovascular Systems, Inc. (CSI) makes an atherectomy system used in treating peripheral and coronary artery disease, adding complementary technologies to Abbott's portfolio of vascular device offerings.
CSI's atherectomy system adds complementary technologies to Abbott's portfolio of vascular device offerings.
Complementary atherectomy technology for Abbott Vascular. Integrated into Abbott's Medical Devices (Vascular) business
No advisory firms have been disclosed for this transaction.